Integrated BioPharma, Inc. (OTCMKTS:INBP – Get Free Report) was up 0.4% on Monday . The company traded as high as $0.33 and last traded at $0.32. Approximately 42,400 shares were traded during mid-day trading, an increase of 305% from the average daily volume of 10,462 shares. The stock had previously closed at $0.32.
Integrated BioPharma Stock Performance
The company’s 50 day moving average price is $0.31 and its 200-day moving average price is $0.25. The company has a market cap of $9.62 million, a price-to-earnings ratio of 15.88 and a beta of 0.59.
Integrated BioPharma Company Profile
Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.
Further Reading
- Five stocks we like better than Integrated BioPharma
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- ESG Stocks, What Investors Should Know
- 2 Drone Stocks Surging from Increased Media Attention
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
